Journal of Clinical Endocrinology & Metabolism, Vol 80, 2447-2450, Copyright © 1995 by Endocrine Society

ARTICLES

Comparison of markers for bone formation and resorption in premenopausal and postmenopausal subjects, and osteoporosis patients

K Kushida, M Takahashi, K Kawana and T Inoue
Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Japan.

Recently, the biochemical markers for bone metabolism have been developed and are expected to reflect the minor change of bone turnover. We compared bone formation markers: alkaline phosphatase- (Alp), bone gla-protein(BGP), carboxy-terminal propeptide of type I collagen(PICP); and bone resorption markers: carboxy-terminal telopeptide of type I collagen(ICTP), pyridinoline(Pyr), deoxypyridinoline(Dpyr) to see if they reflected the effects of aging and menopause in 95 premenopausal and 66 postmenopausal healthy subjects. We also compared the bone turnover in 29 vertebral osteoporosis patients. All markers except ICTP significantly increased with age in the healthy subjects. Alp, BGP, PICP, Pyr, and Dpyr were significantly higher in the postmenopausal group than in the premenopausal group. BGP, Pyr, and Dpyr in premenopausal subjects in their 50s were already significantly increased compared with BGP, Pyr, and Dpyr in premenopausal subjects in their 30s and 40s. To evaluate the discrimination power of the six markers in the postmenopausal subjects and in patients with osteoporosis, the z scores of six markers were calculated against the premenopausal group. z-scores of bone resorption markers(ICTP, Pyr, and Dpyr) were much higher than those of bone formation markers (Alp, BGP, and PICP) in patients with osteoporosis, even though z-scores of bone resorption markers were similar to those of bone formation markers in postmenopausal subjects. In conclusion, Alp, BGP, PICP, Pyr, and Dpyr had good performance in postmenopausal status. Resorption markers increased more than formation markers in osteoporosis subjects, and the bone turnover in osteoporosis subjects was more uncoupled than in postmenopausal subjects.

This article has been cited by other articles:

				H. W. Vesper, L. M. Demers, R. Eastell, P. Garnero, M. Kleerekoper, S. P. Robins, A. K. Srivastava, G. R. Warnick, N. B. Watts, and G. L. Myers Assessment and Recommendations on Factors Contributing to Preanalytical Variability of Urinary Pyridinoline and Deoxypyridinoline Clin. Chem., February 1, 2002; 48(2): 220 - 235. [Abstract] [Full Text] [PDF]

				G. Osella, M. Terzolo, and G. Reimondo Bone and Collagen Turnover in Patients with Active and Preclinical Cushing's Syndrome and in Subjects with Adrenal Incidentaloma--Authors' Response J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2605a - 2606. [Full Text]

				E. A. Amama, M. Taga, and H. Minaguchi The Effect of Gonadotropin-Releasing Hormone Agonist on Type I Collagen C-Telopeptide and N-Telopeptide: the Predictive Value of Biochemical Markers of Bone Turnover J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 333 - 338. [Abstract] [Full Text]

				H. W. Woitge, C. Scheidt-Nave, C. Kissling, G. Leidig-Bruckner, K. Meyer, A. Grauer, S. H. Scharla, R. Ziegler, and M. J. Seibel Seasonal Variation of Biochemical Indexes of Bone Turnover: Results of a Population-Based Study J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 68 - 75. [Abstract] [Full Text]

				A.-M. Heikkinen, M. Parviainen, L. Niskanen, M. Komulainen, M. T. Tuppurainen, H. Kroger, and S. Saarikoski Biochemical Bone Markers and Bone Mineral Density during Postmenopausal Hormone Replacement Therapy with and without Vitamin D3: A Prospective, Controlled, Randomized Study J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2476 - 2482. [Abstract] [Full Text] [PDF]

				A. Siddiqi, J. M. Burrin, K. Noonan, I. James, D. F. Wood, C. P. Price, and J. P. Monson A Longitudinal Study of Markers of Bone Turnover in Graves' Disease and Their Value in Predicting Bone Mineral Density J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 753 - 759. [Abstract] [Full Text] [PDF]